Full Press Release Details
John Quisel, JD, PhD Joins Disc Medicine as President and Chief Executive Officer.
IRON
John Quisel, JD, PhD Joins Disc Medicine as President and Chief Executive Officer
Key Takeaway: John Quisel, JD, PhD Joins Disc Medicine as President and Chief Executive Officer
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+45%
120-day peak, hindsight
Typical move
3.9%
average across 7 past catalysts
Cash runway
~48 mo
Minimal dilution risk
Lead asset
DISC-0974
Phase 2 · Inflammatory Bowel Disease (IBD)